[1]
James S., “Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparin”, ujms, vol. 109, no. 2, pp. 71–122, Jul. 2009.